Inotiv announces St. Louis expansion plans – WISH-TV | Indianapolis News | Indiana Weather
by: Reed Parker, Inside INdiana Business
Posted: Apr 19, 2021 / 10:23 AM EST / Updated: April 19, 2021 / 10:50 AM EST
WEST LAFAYETTE, Indiana (Inside INdiana Business) – West Lafayette-based Inotiv Inc. (Nasdaq: NOTV), a non-clinical and analytical contract research company, has announced that it is expanding its St. Louis business by nearly $ 5 million.
Inotiv says the expansion will provide more comprehensive and integrated services, particularly in support of the company’s recent acquisitions of HistoTox Labs Inc. and Bolder BioPATH Inc.
Inotiv plans to exercise the company’s option to purchase the 50,000 square foot St. Louis facility and complete the expansion as soon as the company receives business incentives. Stewart Jacobson, vice president of Inotiv Sr., says the expansion would include the addition of office and laboratory space.
“The planned strategic expansion of our laboratory in the areas of DMPK, cell and molecular biology and investigative pathology will extend Inotiv’s reach to earlier stages of drug discovery and ultimately increase the commitment of our pharmacological and toxicological operations as well as histopathological services.”